Wells Fargo & Company En V Veno Medical Corp Transaction History
Wells Fargo & Company
- $434 Billion
- Q3 2024
A detailed history of Wells Fargo & Company transactions in En V Veno Medical Corp stock. As of the latest transaction made, Wells Fargo & Company holds 2,000 shares of NVNO stock, worth $5,200. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,000
Previous 2,000
-0.0%
Holding current value
$5,200
Previous $10,000
40.0%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding NVNO
# of Institutions
42Shares Held
5.61MCall Options Held
89.3KPut Options Held
5.2K-
Kingdon Capital Management, L.L.C. New York, NY859KShares$2.23 Million0.35% of portfolio
-
Perceptive Advisors LLC New York, NY694KShares$1.81 Million0.06% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT597KShares$1.55 Million0.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA589KShares$1.53 Million0.0% of portfolio
-
Alyeska Investment Group, L.P. Chicago, IL425KShares$1.11 Million0.01% of portfolio
About enVVeno Medical Corp
- Ticker NVNO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 9,469,850
- Market Cap $24.6M
- Description
- enVVeno Medical Corporation, a medical device company, focuses on the development of various bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous diseases. The company's lead product is the VenoValve, a surgical implant being developed for the treatment of severe deep venous chronic venous insufficiency...